Theratechnologies Inc (THERF) 1.1526

New Post Public Reply Private Reply Replies (0) Message Board
Stock_Tracker
Theratechnologies Inc (THERF) 1.1526 $THERF

Authorization to Discontinue Class Action Proceedings Against Theratechnologies Granted
Marketwired - Fri May 15, 10:00AM CDT
Theratechnologies Inc. (TSX: TH) today announced that the Superior Court of Quebec has authorized 121851 Canada Inc. to discontinue all class action proceedings filed pursuant to the Securities Act (Quebec) and the Civil Code of Quebec against the Company, a director and a former president and chief executive officer.
TH.TO: 1.39 (+0.04)

Cognitive Impairment - Pipeline Review, H1 2015
M2 - Thu May 14, 5:26AM CDT
Research and Markets (http://www.researchandmarkets.com/research/z64d6n/cognitive) has announced the addition of the "Cognitive Impairment - Pipeline Review, H1 2015" report to their offering. This report provides comprehensive information on the therapeutic development for Cognitive Impairment, complete with comparative analysis at various stages, therapeutics assessment by drug target, mechanism of action (MoA), route of administration (RoA) and molecule type, along with latest updates, and featured news and press releases. It also reviews key players involved in the therapeutic development for Cognitive Impairment and special features on late-stage and discontinued projects. The report enhances decision making capabilities and help to create effective counter strategies to gain competitive advantage. It strengthens R&D pipelines by identifying new targets and MOAs to produce first-in-class and best-in-class products. Companies Involved in Therapeutics Development - AbbVie Inc. - AstraZeneca PLC - Avineuro Pharmaceuticals, Inc. - Boehringer Ingelheim GmbH - Bristol-Myers Squibb Company - Dart NeuroScience LLC - Eisai Co., Ltd. - Eli Lilly and Company - Evotec AG - F. Hoffmann-La Roche Ltd. - FORUM Pharmaceuticals Inc. - H. Lundbeck A/S - Iproteos S.L. - Merck & Co., Inc. - Mithridion, Inc. - Mnemosyne Pharmaceuticals, Inc. - Neuralstem, Inc. - Novartis AG - Panacea Pharmaceuticals, Inc. - Pfizer Inc. - Pherin Pharmaceuticals, Inc. - Sanofi - Shire Plc - Suven Life Sciences Ltd. - Takeda Pharmaceutical Company Limited - Teva Pharmaceutical Industries Limited - Theratechnologies Inc. - Upsher-Smith Laboratories, Inc. - Vicore Pharma AB - Virogenomics, Inc. For more information visit http://www.researchandmarkets.com/research/z64d6n/cognitive
PFE: 33.99 (+0.05), LLY: 72.90 (-0.16), BMY: 67.64 (+0.19), AZN: 69.29 (-0.81), MRK: 60.23 (+0.45), SHPG: 254.45 (+3.99), TEVA: 60.23 (-0.99), ABBV: 65.99 (+0.02), CUR: 1.70 (-0.04), NVS: 103.75 (-0.15)

Supreme Court of Canada Rules in Favour of Theratechnologies
Marketwired - Fri Apr 17, 9:09AM CDT
Theratechnologies Inc. (TSX: TH) announced today that the Supreme Court of Canada has granted its appeal and dismissed 121851 Canada Inc.'s motion for leave to commence an action based on the secondary market liability provisions of the Securities Act (Quebec) against Theratechnologies, one of its directors and a former president and chief executive officer.
TH.TO: 1.39 (+0.04)

Theratechnologies Announces Financial Results for First Quarter of 2015
Marketwired - Tue Apr 14, 6:01AM CDT
Theratechnologies Inc. (Theratechnologies) (TSX: TH) today announced its financial results for the first quarter ended February 28, 2015.
TH.TO: 1.39 (+0.04)

Theratechnologies to Announce Financial Results for the First Quarter of 2015
Marketwired - Tue Apr 07, 11:43AM CDT
Theratechnologies Inc. (TSX: TH) (Theratechnologies) announced today that it will issue its financial results for the first quarter ended February 28, 2015, on Tuesday, April 14, 2015, before markets open.
TH.TO: 1.39 (+0.04)

IIROC Trade Resumption - Theratechnologies Inc.
Newsfile Corp - Tue Mar 31, 7:00AM CDT
Trading resumes in:

Health Canada Approves 1mg/vial Presentation of EGRIFTA(TM) (tesamorelin for injection)
Marketwired - Mon Mar 30, 3:28PM CDT
Theratechnologies Inc. (Theratechnologies) (TSX: TH) is pleased to announce that Health Canada has approved a Supplement to a New Drug Submission for the 1mg/vial presentation of EGRIFTA(TM) (tesamorelin for injection) (EGRIFTA(TM)).
TH.TO: 1.39 (+0.04)

IIROC Trade Halt - Theratechnologies Inc.
Newsfile Corp - Mon Mar 30, 2:59PM CDT
The following issues have been halted by IIROC:

Theratechnologies Announces Voluntary Filing of Form 15 to Suspend SEC Reporting Obligations
Marketwired - Tue Feb 03, 6:16AM CST
Theratechnologies Inc. (TSX: TH) today announced that it has filed a Form 15 with the Securities and Exchange Commission ("SEC" under the Securities Exchange Act of 1934, as amended, (the "Exchange Act" to suspend its reporting obligations under Section 15(d) of the Exchange Act.
TH.TO: 1.39 (+0.04)

Theratechnologies Announces Financial Results for Third Quarter of 2014
Marketwired - Wed Oct 08, 6:01AM CDT
Theratechnologies Inc. (Theratechnologies) (TSX: TH) today announced its financial results for the third quarter ended August 31, 2014.
TH.TO: 1.39 (+0.04)

Theratechnologies to Announce Financial Results for the Third Quarter of 2014
Marketwire - Wed Oct 01, 3:11PM CDT
Theratechnologies Inc. (TSX: TH) (Theratechnologies) announced today that it will issue its financial results for the third quarter ended August 31, 2014, on Wednesday, October 8, 2014, before markets open.
TH.TO: 1.39 (+0.04)

Theratechnologies Resumes Distribution of EGRIFTA(R) (Tesamorelin for Injection) in the United States
Marketwire - Wed Sep 03, 5:18PM CDT
Theratechnologies Inc. (TSX: TH) is pleased to announce that a first shipment of EGRIFTA(R) (tesamorelin for injection) was sent to its U.S.-based wholesale distributor in order to replenish the supply chain. As a consequence, EGRIFTA(R) will once again be available to patients in the United States by mid-September, as planned.
TH.TO: 1.39 (+0.04)

Scroll down for more posts ▼

Top 10 Most Recent News Articles

Alley Cat Allies Pushes for Humane Cat Conservation Bill

Updated Category News Views 70

Time to Rethink Conservation: Save the Cats If you’re tuned into the chatter buzzing around the Cayman Islands, you know the clocks are ticking for a decision that could change the approach to handling community cats. Alley Cat Allies is waving the flag, urging the Cayman Islands Parliament to pass a bill that abandons the archaic practice of culling cats by shooting...

Continue Reading
Luxury Villa Cashback Offers Entice Travelers in November

Updated Category News Views 134

A November Bonanza for Villa Bookings Who doesn't love having a few extra bucks in their pocket, especially when they come with the allure of luxury travel? Villas of Distinction is rolling out what they call a 'November Cashback Offer,' and for those with the wallet—and wanderlust—to match, it could be a tempting proposition. Hanging the bait of up to $2,000 cashback...

Continue Reading
Duolingo Faces Class Action: Key Investor Steps

Updated Category News Views 126

Navigating Turbulent Times with Duolingo Holy moly, the dumpster fire that is the Duolingo (NASDAQ:DUOL) legal saga just got hotter. If you snagged yourself some shares between May 2, 2025, and February 26, 2026, you'd better sit down and grab some antacids—because the nauseating roller coaster is far from over. Robbins LLP is rounding up the troops for a class action,...

Continue Reading
Daymond John's Four-Center Bet on Longevity Game

Updated Category News Views 210

A Shark's Dive into Longevity Here you go—Daymond John, the face of FUBU and a household name from Shark Tank, is not just talking about living longer; he's putting his wallet where his words are. John is jumping into the longevity game with both feet, joining Ultimate Longevity Center's (ULC) latest venture. We're talking about four new centers across California,...

Continue Reading
Tenax Class Action: Investors Alley Fight for Redress

Updated Category News Views 144

Tenax Therapeutics in Hot Water Over Drug Trial Results Amidst the ever-unpredictable tides of the pharmaceutical industry, here comes a doozy – Tenax Therapeutics, Inc. is neck-deep in a shareholder lawsuit. If you tossed some money at NASDAQ:TENX anytime between November 13, 2023, and August 7, 2026, you might be feeling the sting of regret, and rightly so. What Went...

Continue Reading
Kinross Gold Fraud Lawsuit: What Shareholders Need to Know

Updated Category News Views 64

Kinross Gold's Legal Quagmire There's a fresh storm brewing for Kinross Gold Corporation (NYSE: KGC), and it ain't the kind investors enjoy riding. You see, the company is up to its neck in a class action lawsuit, courtesy of Schall, Brown & Schwartz LLP—a big-name shareholder rights litigation outfit. The gripe? Alleged securities fraud, violating §§10(b) and 20(a)...

Continue Reading
TCL Unveils Black Friday Steals on Smart Devices

Updated Category News Views 157

TCL's Big Move This Holiday Season When was the last time you saw a deal that actually made you stop and check your wallet? Well, TCL is giving you a reason to dig deep this Black Friday and Cyber Monday. They're slashing prices across smartphones and tablets, trying to elbow their way into your shopping cart with discounts up to $150. Now that's the kind of aggressive...

Continue Reading
Lilly Endowment Boosts Military Families with $10M Grant

Updated Category News Views 78

A Game-Changer for Semper Fi & America's Fund Dive in, folks. What we've got here is a hefty chunk of change — $10 million to be precise — dropped into Semper Fi & America's Fund's lap by Lilly Endowment Inc. We're talking about a grant designed to shore up the long-term support system crafted for the brave souls in military families. It’s about time a significant...

Continue Reading
Arbor Realty Trust Hit with Securities Fraud Lawsuit

Updated Category News Views 110

Snafu at Arbor Realty: Investors Rethink Strategies You know what puts a bee in my bonnet these days? Misleading statements from companies like Arbor Realty Trust, Inc. (NYSE: ABR). The news breaks that Arbor's got itself neck-deep in a class action lawsuit, courtesy of the sharp folks over at Schall, Brown & Schwartz LLP. Now, this ain't your average financial hiccup....

Continue Reading
LA Hospitals Shine in Pulmonary Excellence Nationwide

Updated Category News Views 150

Los Angeles Community Hospitals' Recent Recognition You ever stroll into a hospital and wonder if you’re really getting the best care? Well, the folks over at Los Angeles Community Hospitals, covering LA, Norwalk, and Bellflower, just got a big nod from Healthgrades—yeah, the site everyone's checking to find decent healthcare options. They’ve landed among the top...

Continue Reading

Top 5 Most Recently Viewed Articles

Vinanz Boosts Bitcoin Mining Operations with New Hardware

Updated Category News Views 160

Vinanz Limited Enhances Bitcoin Mining Capacity Vinanz Limited (US OTCQB: VINZF and AQSE: BTC) has taken a significant step forward in its operations by activating new Bitcoin mining hardware in Nebraska. This move aligns with its broader strategy to expand Bitcoin mining capabilities across North America. Introduction of Advanced Mining Technology The recent deployment...

Continue Reading
Recent Transparency Notification by Nyxoah - Key Insights

Updated Category News Views 202

Understanding Nyxoah's Recent Transparency Notification REGULATED INFORMATION Mont-Saint-Guibert – In alignment with disclosure requirements regarding shareholding changes, Nyxoah SA (Euronext Brussels/Nasdaq: NYXH) has announced an important transparency notification. Who is Vestal Point Capital? On October 23, Nyxoah disclosed that it received a transparency...

Continue Reading
Mural Oncology Set to Showcase Research at SITC Annual Meeting

Updated Category News Views 48

Mural Oncology Set to Showcase Research at SITC Annual Meeting Mural Oncology plc (NASDAQ: MURA), a pioneering company focused on immuno-oncology, is gearing up for a significant event—the 39th Annual Meeting of the Society for Immunotherapy of Cancer (SITC). This important gathering will take place from November 6-10, 2024, in Houston, Texas. Mural Oncology is excited...

Continue Reading
Genmab A/S Announces Share Buyback Progress and Strategy

Updated Category News Views 128

Overview of Genmab's Share Buyback Program Genmab A/S has initiated an impressive share buyback program aimed at enhancing shareholder value. The program, announced on March 25, is designed to repurchase up to 2.2 million shares as part of its strategy to reduce capital and fulfill commitments under the Restricted Stock Unit program. Recent Transactions Under the Buyback...

Continue Reading